Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone for bipolar I depression (China phase 3)
CTR20200256Phase 3Terminated
- Sponsor
- Sunovion
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lurasidone in bipolar I disorder, sponsored by Sunovion. Started Apr 2020; status: terminated.
02
Drugs
lurasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on CTR20200256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200256.